These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 27091202)
1. C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study. Hobusch GM; Bodner F; Walzer S; Marculescu R; Funovics PT; Sulzbacher I; Windhager R; Panotopoulos J World J Surg Oncol; 2016 Apr; 14():111. PubMed ID: 27091202 [TBL] [Abstract][Full Text] [Related]
2. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725 [TBL] [Abstract][Full Text] [Related]
4. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma? Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in surgical resection of sacral chordoma. Angelini A; Pala E; CalabrĂ² T; Maraldi M; Ruggieri P J Surg Oncol; 2015 Sep; 112(4):344-51. PubMed ID: 26238085 [TBL] [Abstract][Full Text] [Related]
6. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database. Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601 [TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of sacral chordoma: survival and prognostic factors. Ruosi C; Colella G; Di Donato SL; Granata F; Di Salvatore MG; Fazioli F Eur Spine J; 2015 Nov; 24 Suppl 7():912-7. PubMed ID: 26458933 [TBL] [Abstract][Full Text] [Related]
8. Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute. Yang Y; Niu X; Li Y; Liu W; Xu H Eur Spine J; 2017 Jul; 26(7):1910-1916. PubMed ID: 27942938 [TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma. Chen KW; Yang HL; Lu J; Wang GL; Ji YM; Wu GZ; Zhu LF; Liu JY; Chen XQ; Gu YP J Neurooncol; 2011 Feb; 101(3):357-63. PubMed ID: 20549300 [TBL] [Abstract][Full Text] [Related]
10. The impact of radiotherapy on survival after surgical resection of chordoma with minimum five-year follow-up. Tobert DG; Kelly SP; Xiong GX; Chen YL; MacDonald SM; Bongers ME; Lozano-Calderon SA; Newman ET; Raskin KA; Schwab JH Spine J; 2023 Jan; 23(1):34-41. PubMed ID: 35470086 [TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710 [TBL] [Abstract][Full Text] [Related]
12. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution. van Wulfften Palthe ODR; Tromp I; Ferreira A; Fiore A; Bramer JAM; van Dijk NC; DeLaney TF; Schwab JH; Hornicek FJ Spine J; 2019 May; 19(5):869-879. PubMed ID: 30445184 [TBL] [Abstract][Full Text] [Related]
13. High expression of survivin in sacral chordoma. Chen C; Yang HL; Chen KW; Wang GL; Lu J; Yuan Q; Gu YP; Luo ZP Med Oncol; 2013 Jun; 30(2):529. PubMed ID: 23504337 [TBL] [Abstract][Full Text] [Related]
14. Oncologic and functional outcome following sacrectomy for sacral chordoma. Hulen CA; Temple HT; Fox WP; Sama AA; Green BA; Eismont FJ J Bone Joint Surg Am; 2006 Jul; 88(7):1532-9. PubMed ID: 16818979 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence. Zhang K; Chen H; Zhang B; Sun J; Lu J; Chen K; Yang H Int J Clin Exp Pathol; 2015; 8(1):608-14. PubMed ID: 25755752 [TBL] [Abstract][Full Text] [Related]
16. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634 [TBL] [Abstract][Full Text] [Related]
17. Late local recurrence, at 19 and 17 years, of sacral chordoma treated by en bloc resection. Dubory A; Missenard G; Court C Orthop Traumatol Surg Res; 2016 Feb; 102(1):121-5. PubMed ID: 26796999 [TBL] [Abstract][Full Text] [Related]
18. Sacral chordoma: do the width of surgical margin and the use of photon/proton radiotherapy affect local disease control? Fujiwara T; Tsuda Y; Stevenson J; Parry M; Jeys L Int Orthop; 2020 Feb; 44(2):381-389. PubMed ID: 31863159 [TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization. Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296 [TBL] [Abstract][Full Text] [Related]
20. Chordoma: long-term evaluation of 15 cases treated surgically. Logroscino CA; Astolfi S; Sacchettoni G Chir Organi Mov; 1998; 83(1-2):87-103. PubMed ID: 9718818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]